mTOR Pathway Expression as Potential Predictive Biomarker in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus
Fabio Gelsomino(University of Modena and Reggio Emilia), Gabriele Luppi(University of Modena and Reggio Emilia)
Cited by 11
Related Papers
The value of c-kit mutational analysis in a cytokeratin positive gastrointestinal stromal tumour
|Journal of Clinical Pathology|2005|25
New Frontiers of Biomarkers in Metastatic Colorectal Cancer: Potential and Critical Issues
|International Journal of Molecular Sciences|2025|6